GERAGHTY JAMES A — SEC Form 4 filings
SEC reporting owner CIK 1239746. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-24 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1 shares, $1 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 1 shares @ $1.00 ($1) in PIERIS PHARMACEUTICALS, INC., filed 2024-10-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. (PIRS) | Director | 2 | 1 leg · 1 sh · $1 | — | 1 |
| Fulcrum Therapeutics, Inc. (FULC) | Director | 3 | — | — | 3 |
| Orchard Therapeutics plc (ORTX) | Director | 1 | — | — | 3 |
| Voyager Therapeutics, Inc. (VYGR) | Director | 3 | — | — | 3 |
Form 4 filings — GERAGHTY JAMES A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Disposition to issuer (D): 1 @ $0.01 | EDGAR |
| 2024-10-28 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Purchase (P): 1 @ $1 | EDGAR |
| 2024-06-18 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Orchard Therapeutics plc (ORTX) | Disposition to issuer (D): 44,391 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1239746 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →